<正> The title compound, C15H30N2PdCl2 (Mr=427.73), crystallizes in two kinds of crystal forms I and II.I : monoclinic, P21/c, a = 8.234(1), b = 13.702(3), c = 8.939(2) A, β = 93.90(1)°, V = 1010.55 A3, DC = 1.407g/cm3, R = 0.032 for 2098 observed reflections.II: triclinic, Pl, a=8.179(1), b=8.182(1). c=8.231(2) A, α=91.89(1)°, β=91.90(2)°, α=113.80(1)°, V =503.09A3, DC =1.413 g/cm3, R = 0.036 for 1770 observed reflections.The molecules in both crystals I and II possess the identical configurations but there are two orientations of molecules in the crystal II.
展开▼
机译:First crystal structure of a (mu-oxamidato)tricopper(II)metal(II)-type tetranuclear complex: Synthesis, crystal structure, and magnetism of a copper(II)manganese(II) complex ((Cu3MnII)-Mn-II(mu-L)(3)(N-3)(2)center dot EtOH) incorporating a macrocyc
机译:ChemInform Abstract: Preparation and Structure of Dichloropalladium(II) Complexes of Sterically Protected Diphosphinidenecyclobutenes and Their Synthetic Application as Homogenous Catalyst.
机译:Structure Determination and Mechanistic Insights of: I.Cyanobacteriochrome NpR6012g4 Light Sensor Protein in Phototaxis II.Retinal Degeneration 3 (RD3) Protein in Vision III.Ryanodine Receptor 2 (RyR2) Regulation by Calmodulin (CaM) in Cardiac Function =结构测定和机理洞悉:I.趋光性中的蓝细菌色素NpR6012g4光敏蛋白 II.视觉作用中的视网膜退化蛋白3 III.心脏功能中的钙调蛋白调控兰诺定受体2